keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Canagliflozin (JNJ 28431754AAA), a sodium-glucose transporter 2( SGLT2) and P-Glycoprotein inhibitor, is used in type 2 diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 43.00 | |
10 mg | In stock | $ 61.00 | |
50 mg | In stock | $ 97.00 | |
100 mg | In stock | $ 125.00 | |
200 mg | In stock | $ 185.00 | |
500 mg | In stock | $ 313.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 48.00 |
Description | Canagliflozin (JNJ 28431754AAA), a sodium-glucose transporter 2( SGLT2) and P-Glycoprotein inhibitor, is used in type 2 diabetes. |
Targets&IC50 | SGLT2 (rat):3.7 nM, SGLT2 (mouse):2 nM, SGLT2 (human):4.4 nM |
In vitro | In oocytes injected with SGLT3, Canagliflozin (10 μM) inhibits the DNJ-induced current. It also suppresses the uptake of 14C-AMG in CHO-hSGLT1 cells (IC50=0.7 μM) and mSGLT1 cells (IC50=>1 μM). Additionally, in L6 myoblasts, Canagliflozin inhibits the absorption of 2H-2-DG regulated by GLUT that is not associated with Na+ (non-Na+-linked). |
In vivo | In KK mice fed a high-fat and high-sugar diet, oral administration of Canagliflozin (3 mg/kg) demonstrated a significant anti-hyperglycemic effect. Similarly, in male SD rats, oral ingestion of Canagliflozin (30 mg/kg) induced glucose excretion and effectively reduced blood sugar levels. |
Cell Research | Cells from the rat skeletal muscle cell line, L6, is used to test the effect of Canagliflozin on glucose transporter 1 (GLUT1) activity. Cells are maintained in Dulbecco's modified Eagle's medium containing 5.6 mM glucose supplemented with 10% fetal bovine serum, are seeded in 24-well plates at a density of 3 × 105 cells/well and cultured for 24 hours in an atmosphere of 5% CO2 at 37 °C. Cells are rinsed twice with Kreb's ringer phosphate HEPES buffer (pH 7.4, 150 mM NaCl, 5 mM KCl, 1.25 mM MgSO4, 1.25 mM CaCl2, 2.9 mM Na2HPO4, 10 mM HEPES) and are pre-incubated with the solutions of Canagliflozin (250 μL, 10 μM) for 5 minutes at room temperature. The transport reaction is initiated by adding 50 μL of 4.5 mM 2-DG (a substrate for GLUTs)/3H-2-DG (0.625 μCi) followed by incubation for 15 minutes at room temperature. The 2-DG uptake is halted by aspiration of the incubation mixture. Cells are immediately washed 3 times with ice-cold PBS. Samples are extracted with 0.3 N NaOH, and radioactivity is determined by liquid scintillation.(Only for Reference) |
Synonyms | JNJ 24831754ZAE, JNJ 28431754AAA, TA 7284, JNJ 28431754 |
Molecular Weight | 444.52 |
Formula | C24H25FO5S |
CAS No. | 842133-18-0 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 82 mg/mL (184.5 mM)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Canagliflozin 842133-18-0 GPCR/G Protein SGLT Sodium-dependent glucose cotransporters TA-7284 JNJ 24831754ZAE JNJ 28431754AAA TA 7284 JNJ-28431754 Inhibitor JNJ 28431754 inhibit JNJ28431754 TA7284 inhibitor